Interview with Carlos del Rio, MD, author of Long-term Health Consequences of COVID-19 Related Article: Long-term Health Consequences of COVID-19
JAMA Pediatrics Editors' Summary by Dimitri Christakis, MD, MPH, Editor in Chief, and Frederick Rivara, MD, MPH, Editor in Chief of JAMA Network Open for the November 2, 2020 issue.
Tim Uyeki, MD, chief medical officer for the Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), discusses how the COVID-19 pandemic may affect the 2020-2021 influenza season. Related Article: Preparing for the 2020-2021 Influenza Season
Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the latest developments in the COVID-19 pandemic, including the continued importance of nonpharmaceutical interventions (masking, handwashing, physical distancing) for managing rising case numbers in the US and globally. Recorded October 28, 2020. Related Article(s): Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions
Paul A. Offit, MD, of the Children's Hospital of Philadelphia, returns to JAMA's Q&A series to provide an update on progress in COVID-19 vaccine development. Recorded October 27, 2020. Related Article(s): Developing a SARS-CoV-2 Vaccine at Warp Speed
John S. Brownstein, PhD and Douglas L. Kriner, PhD join JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a survey study evaluating the factors associated with US adults’ choice of and willingness to accept a hypothetical COVID-19 vaccine. Read the article here: https://ja.ma/3e0Rz3i. JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.
Large Meta-analysis Digs Into Obesity’s COVID-19 Risks; As Their Numbers Grow, COVID-19 “Long Haulers” Stump Experts; Telephone Visits Surge During the Pandemic, but Will They Last? Related articles: Large Meta-analysis Digs Into Obesity’s COVID-19 Risks As Their Numbers Grow, COVID-19 “Long Haulers” Stump Experts Telephone Visits Surge During the Pandemic, but Will They Last?
Interview with Aaron L. Baggish, MD, and Jonathan H Kim, MD, authors of Coronavirus Disease 2019 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return to Play, and James E. Udelson, MD, author of Return to Play for Athletes After Coronavirus Disease 2019 Infection—Making High-Stakes Recommendations as Data Evolve
Rochelle P. Walensky, MD, MPH, of Harvard Medical School and Massachusetts General Hospital returns to JAMA's COVID-19 Q&A to provide an update on developments in the pandemic. She is a signatory of the recent John Snow Memorandum emphasizing the importance of public health interventions to manage the spread of COVID-19. Recorded October 22, 2020. Related Article(s): Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions
The costs of the coronavirus pandemic are unprecedented in their dimensions: David M. Cutler, PhD, of Harvard University discusses financial costs: the $16 trillion virus. Lisa Cooper, MD, MPH, of Johns Hopkins University discusses the costs to communities of color in excess deaths and bereavement. Charles R. Marmar, MD, of NYU Grossman School of Medicine discusses the mental health costs. Recorded October 20, 2020. Related Article(s): The COVID-19 Pandemic and the $16 Trillion Virus